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CBA/Ca male mice have been exposed to benzene in air at 10, 25, 100, 300, 400, and 3000 ppm forvariable
intervals 6 hr/day, 5 days/week forup to 16 weeks. Two weeks ofinhaling 10 ppm produced no hematologic
effects; 25 ppm induced a significant lymphopenia. Inhalation of 100, 300, and 400 ppm produced dose-
dependent decreases in blood lymphocytes, bone marrowcellularity, marrowcontentofspleencolony-forming
units (CFU-S) and an increased fraction ofCFU-S in DNA synthesis. Exposure ofmice to 300 ppm for 2, 4,
8, and 16 weeksproduced severe lymphopenia and decrease in marrow CFU-S. Recovery was rapid and com-
plete after 2 and 4 weeks ofexposure. After 8 and 16 weeks ofexposure, recovery oflymphocytes was com-
plete within 8 weeks. It took 16 weeks for the CFU-S to recover to that ofthe age-matched controls after
8 weeks ofexposure and 25 weeks torecover to age-matched after 16 weeks ofexposure. Inhalation of3000
ppm for8 days was less damagingthan inhalation of300 ppm for 80 days (same integral amountofbenzene
inhaled). The inhalation of 3000 ppm has not increased the incidence ofleukemia or shortened its latency
for development. Inhalation of300 ppm 6 hr/day for 16 weeks significantly increases the incidence ofmy-
elogenous neoplasms in male CBA/Ca mice. Inhalation of 100ppm for same interval does not influence in-
cidence ofmyelogenous neoplasms but does increase incidence of solid neoplasms particularly in female
CBA/Ca mice. Benzene is a potent carcinogen in CBA/Ca mice.
Introduction
Presumably the first reference in the literature to
harmful effects frombenzene is a report of a case ofpur-
pura in 1897 (1). From 1897 through 1950 there were
sporadic case reports associating exposure to benzene to
the development of purpura and leukemia. These are
summarized by Bernard (2). These anecdotal observa-
tions clearly implicated benzene as a hematotoxin. In
1916-1917(3,4)there were two studies onthe role ofben-
zene as a leukotoxin. These studies investigated the de-
generation and regeneration ofhematopoietic tissues of
animals.
Thefirst convincing studies on thepossible role ofben-
zene as aleukemogenic agentinhumanbeings were those
ofAksoy et al. (5-8) andViglianiand Saita(9). Aksoy(5,6)
reported that leukemia in benzene-exposed workers
decreased after the phase-out ofbenzene use in Istanbul,
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and there was no leukemia observed in workers during
the last 3 years ofthe last study, implicating benzene as
a probable causative agent in the earlier intervals.
Detailed epidemiological studies have been performed
suggesting thatthere is alinearno-threshold dose-effect
relationship for induction of leukemia in man (10-13),
which is an unlikelyrelationship. There are alarge num-
ber of uncertainties in the estimation of human cancer
riskbecausemanyoftheimportantconditions withwhich
one is concernedlieoutside the range ofscientific obser-
vation. Infante andWhite(10,12,13)andthe International
Agency for Research on Cancer (14) adopted the un-
proved one-hitlinearmodel, which assumes nothreshold
and that every incremental dose ofbenzene is accompa-
niedby an increment in the excess cancerrisk. The one-
hit hypothesis assumes that there is a single, unique
chemical event that is irreversible, and when this event
isin DNAthereisnorepairoftheinjury. Itiswellknown
that DNA is repaired at times almost completely by
known biochemical mechanisms.
Hoel et al. (15)point out that the relationship between
theapplied doseandincidenceofcancerisfrequentlynon-
linear, but the tumor response in some instances is lin-
ear with resultant concentration ofDNA adducts in the
target organ. It is reasonable to assume that benzene
metabolites, at least in part, will result in DNA adducts
andthatit isunlikelythatfheincidence ofleukemiawillCRONKITE ETAL.
follow a one-hit, no-threshold response to exposure with
graded concentrations of benzene. This may, however,
pertain to adducts of DNA with benzene metabolites.
Previous studies on experimental induction ofleukemia
and other neoplasms bybenzene havegenerally involved
a lifetime exposure. The exposure regimen in the pres-
ent studies was based on the apparent exposure condi-
tions ofhuman beings describedbyAksoy et al. (5-8)and
Vigliani and Saita(9). Human beings commence work in
industry at 18 years or older, thus exposure in mice was
commenced at 12 to 14 weeks ofage, whenthey are sexu-
ally mature. Itwas assumed that humanbeings were ex-
posedfor 16weeks, approximately 15% oftheirlives and,
accordingly mice were exposed for about 15% of their
lifespan. The work days were mimicked by exposingmice
6 hr/day, 5 days/week. The general objectives of these
studies were a) to determine early andlate effects ofben-
zene on hematopoietic stem cells and early effects on the
early hematopoietic progenitors, b) to compare the
hematologic effects induced bythe same total amount of
benzene inhaled over short orlongintervals, and c)to ob-
serve for the induction ofleukemia and other neoplasms
by the exposure regimen outlined above to 300 and 100
ppm of inhaled benzene.
Materials and Methods
Benzene Exposure
Mice were exposed to room air or aircontaining 10, 25,
100, 300, 400, or 3000 ppm benzene in chambers similar
to those described by Hinners et al. (16), anisolation sys-
tem described by Laskin et al. (17), oringlassjar cham-
bers like those described by Leach (18). Benzene concen-
trations were monitored via an automatic gas sampling
system coupled to agas samplingloop Packard Model 417
gas chromatograph orbywet-chemical spectrophotomet-
ric analysis using a bubbler with ethanol as the absorb-
ing solution. Mice were allowed food and water ad libi-
tum except during exposure periods. Exposures were 6
hr/day, 5 consecutive days/week. When not in exposure
chambers animals were housed in temperature- and
humidity-controlled rooms ona 12-hrlight/dark cycle. The
incoming air was passed through HEPA filters and ex-
hausted to the outside. Corn-cob bedding was sterilized
before use and rooms were maintained pathogen free.
Hematopoietic Stem Cells and
Early Progenitors
Atvarious times duringand afterthe exposure period
mice were removedfrom the control andbenzene groups,
anesthetized by ether, bled from the orbital sinus, and
killedby cervical dislocation. Blood counts and assays for
stem cells wereperformed approximately 18 hrafterter-
mination of the exposure period or at the times desig-
nated. Peripheral blood values were determined with a
Technicon H-1 hematology analyzer.
Hematopoietic stem cells (HSC) were assayed by
removing hind legs and flushing out the bone marrow
from tibia andfemur. Total marrow cellularity was deter-
minedfrom the resultant suspensions with a Coulterelec-
tronic counter. An aliquot ofsome bone marrow suspen-
sions was subjected to tritiated thymidine (H3Tdr)
cytocide (19)to determine fraction in DNA synthesis. The
spleen colony assay of Till and McCulloch (20) was used
for determination of the number of pluripotent
hematopoietic stem cells in the bone marrow. Recipient
mice were given 850 rad from 250 kVp, 30 mA GE Max-
itron X-ray machine with 1 mm aluminum and 0.5 mm
copper filtration at a dose rate of90 to 100 rad/min for 2
hrbefore beingusedfor assay. Fifty thousand nucleated
bone marrow cells from the individual orpooled suspen-
sions above weregiven IV. The recipients were killed 10
days afterinjection. The spleenswere removed, fixed in
Bouin's solution, and the surface colonies counted.
To test the functional capacity ofthe stem cells in mice
exposed to benzene, a rescue assay was used. Animals
were exposedfor 16weeks to 300 ppm. Benzene-exposed
and sham-exposed, age-matchedmice were allowedto re-
coverformore than2years(752 days). Atthattime they
were used as bone marrow donors to start a serial res-
cue assayin whichrecipients were fatallyirradiated(850
rad) and then given 10 bone marrow cells IV from the
sham- or benzene-exposed donor groups. Surviving
recipients at 30 days after rescue transplant were then
used asbone marrow donors for a subsequent rescue as-
say. Thisprocedure was carried outfor three successive
rescues.
In selectedexperiments, assays ofearlyprogenitors of
erythrocytic cells andgranulocytic cells were performed.
To culture the 2-day erythrocyte colony-forming units
(CFU-E), the method of McLeod et al. (21) was used.
Briefly, control and benzene-treated bone marrow
(femurs and tibias)were harvested inminimumessential
medium with2% fetal calfserum. The suspensions were
passed through 26- and 27-gauge needles successively.
Total cell counts were determined by Coulter Electronic
Counter. After48 hr ofincubation, theplasma clots were
fixed in situ in 5% glutaraldehyde, washed in water,
transferred to slides, and stained with benzidine and
hematoxylin. Four clots per group were scored for
erythrocytic colonies containing eight or more benzidine-
positive cells.
Eight-dayburst-formingunits(BFU-E-8)were cultured
in erythropoietin 2.5 units/mL and pokeweed-mitogen
condition medium(2.5% solution). Apokeweedmitogen-
conditioned medium wasprepared as described byJohn-
son and Metcalf(22). The plasma clots were cultured at
370C, 7% carbon dioxide. Clots were harvested on days
3 and 8. Halfthe clots were fixed in 5% glutaraldehyde
and stained withbenzidine andhematoxylin. Halfofthe
remaining clots were fixed in 10% formalin and stained
with acetylcholine esterase and hematoxylin in order to
identify megakaryocyte-containing clots. The clots were
surveyed at 7.5x magnification and apositive identifica-
tion of the colonies and bursts were made at 40x mag-
nification.
The assays for early progenitors ofgranulocytes and
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macrophages(CFU-G, CFU-GM) wereperformed in agar
cultures identical to the method of Pike and Robinson
(23).
Mice
In studies on long-term effects ofbenzene on peripheral
blood and HSC and leukemo-carcinogenesis, CBA/Ca
BNL male andfemale micewere used. Exposure ofmice
was commenced at84 days ofage. Carcasses ofdeadmice
were opened and fixed in 5% buffered formalin. Tissues
were embeddedinparaffin, sectionedat7tim, and stained
withhematoxylin and eosin. Inthe serial rescue and some
other HSC studies, C57BL/6BNL male andfemale mice
were used. For some studies on the effects ofbenzene of
hematopoietic stem cells and early hematopoietic progen-
itors, Hale-Stoner BNL mice were used.
Results
Hematopoietic Stem Cells
These observations have been published previously
(24,25). After exposure to 400ppm benzene, 6hr/day, the
nucleated bone marrow cell count andthe CFU-Sperleg
decreased to about 25% ofthe age-matched controls af-
ter five exposure intervals. Concomitantly, the fraction
ofCFU-S in DNA synthesis increased after 5 days ofex-
posure to 40 to 60% compared to 20% ofthe age-matched
controls. This was maintained through 91/2 weeks of ex-
posure. Aftertermination thefraction in DNA synthesis
diminished to the age-matched control level by 15 days.
There was no significant increase duringthis interval in
the CFU-S level.
In other studies(25), C57BL/6micewereexposedto 10,
25, 100, 300, or400ppmbenzene, 6hr/day, 5 consecutive
days/week, for 2 to 16 weeks. These studies showed no
effect onmarrowcellularity after 10or25ppm, withasig-
nificant diminution in marrow cellularity at exposure to
100 ppm for 2 weeks. Similarly, there was a dose-
dependent effect on diminution ofthe CFU-S after 100
and400ppm. There was also asignificantincrease inthe
fraction in DNA synthesis after 10 exposures to 100 and
400ppm. Two weeks(10exposures)to 10,25, 100, and400
ppm produced a dose-dependent diminution in lympho-
cytes but no effect upon granulocytes in the peripheral
blood. Two weeks after exposure for 2 or 4 weeks, the
stem cells had returned to the normal age-matched con-
trol level. After8weeks ofexposure, ittook 16weeksfor
CFU-S to return to that ofthe age-matched controls. Af-
ter 16 weeks ofexposure there was aslow, nearlylinear
return for 8 weeks with no further increase at 16 weeks
after exposure, butby 25weeks the levelwas thatofthe
age-matched controls. The degree of lymphopenia was
nearly the same after 2, 4, 8, and 16 weeks ofexposure
withrapid recovery by 8weeks afterexposure to that of
the age-matched control animals.
Early Erythrocytic Progenitors
Figure 1 shows the effect of exposure to 400 ppm, 6
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FIGURE 1. Serial changes in the number ofplasma clot CFU-E in pooled
bone marrowofHale-Stoner miceinhaling400ppmbenzene 6hr/day,
5 days/week for 47 exposures (91/2 weeks).
hr/day, 5 days/week, in Hale-Stonermice. Afterone and
four exposures there was no significant change in the
CFU-E. However, after 29 days, 48 days, and 65 days
there was a significant diminution in the number of
CFU-E. Seven days aftertermination ofexposure there
had been no recovery, but by 12 days after exposure
there had been a marked increase to greater than twice
that of the age-ma'tched controls.
Figure 2 illustrates the changes seen in the BFU-E
8-day plus the erythrocytic megakaryocyte-containing
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FIGURE2. Serial changes in8-dayplasmaclot cultures of8-day BFU-E
(o) andgranulocyte macrophage aggregates (x) inpooled bone mar-
row of Hale-Stoner mice inhaling 400 ppm benzene 6 hr/day, 5
days/week for 47 exposures (9% weeks). ER + ER/MK bursts,
erythroid anderythroidmegakaryocyticbursts; GR + GR/MA + MA
aggregates, granulocytic andgranulocytic/macrophages and macro-
phage aggregates.
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bursts. The firstculture was90% ofthe age-matched con-
trol after one exposure. By29 days after commencement
of exposure (22 exposures) very few 8-day bursts re-
mained assayable. Recovery was incomplete 12 days af-
ter termination of exposure.
Figure 2 also illustrates the changes in granulocyte-
macrophage aggregates seen in the plasma clots. There
is a smaller decrease in their number with recovery to
nearly that ofthe age-matched controls 12 days after ter-
mination of exposure.
Figure 3 illustrates the effect upon the CFU-GM in
agar culture plates. The data arepresented as percent of
control and actual number of colonies counted in the
platesfrom thebenzene-treated andthe age-matched con-
trol mice. There is a suggestion of an increase in the
CFU-GM after commencement of exposure, but by 30
days there is a significant diminution and an apparent
partial recovery during continued exposure.
The rather marked changes in the assayable, early
erythropoietic progenitors was reflected in a decrease in
the redblood cell counts duringthe exposure to about50
to 75% ofthe age-matched controls. There were lesser,
oscillating changes in thegranulocyte level in the blood.
Figure 4 shows the results from the three successive
serial rescue transplants. The effectiveness ofbone mar-
rowfrom sham-exposed donors was compared to that of
bone marrow from mice that had been exposed to ben-
zene 752 days earlier. All transplants consisted of 107
bone marrow cells. In the first rescue of mice that had
received 850 rad, the 30-day survival was 100%. At 290
days after rescue, 7% ofthe mice receivingbone marrow
from sham-exposed donors had died and 36% had died of
those receiving bone marrow from benzene-exposed
donors. Again, in the secondarytransplant there were no
30-day deaths in the mice receiving bone marrow from
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FIGURE 3. Serial changes in 7-day agar culture ofGM-CFU-C in bone
marrow of Hale-Stoner mice inhaling 400 ppm benzene 6 hr/day, 5
days/week for 47 exposures (91 weeks).
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FIGURE 4. Serial rescue bone marrow transplantation from donor
C57BL/6BNL mice than had been exposed to benzene 300 ppm 6
hr/day, 5 days/weekfor 16weeks 752 days earlier. 10,20,30, primary,
secondary, andtertiary rescuesinthe series. Numbers inparentheses
are numbers of animals set aside for long-term survival.
sham-exposed or benzene-exposed mice. However,
deaths commenced at 70 days after rescue in those
animals receiving bone marrow from the benzene-
exposed donorswhereasthere were no deaths inthe mice
receiving bone marrow from the sham-exposed until
about 171 days after exposure. In thetertiary rescue the
recipients of the marrow from the original benzene-
exposed donors commenced dying early, and 50% were
dead by 30 days after exposure. By 245 days after ex-
posure 95% were dead, and the last animal died at 595
daysafterradiation. In contrast, with the micereceiving
marrow from the original sham-exposed, there was only
one death duringthefirst30dayswith50% oftheanimals
surviving about375 days andthe last animal dying at594
days after irradiation.
Hematologic Effects ofthe Same Amount
ofBenzene Inhaled over Short or Long
Periods
It was originally intended to compare the effect ofin-
halation ofbenzene over 2 days compared to inhalation
ofthe same total amount over 20 days. To allow assays
1 day following final exposure, 316 ppm, 6 hr/day, 5
days/week for a total of 19 exposures, was compared to
3000 ppm, 6 hr/day for two successive exposures. Fig-
ure 5 shows the effects upon absolute neutrophil and
lymphocyte counts inthe blood. There is adrastic reduc-
tion in the lymphocyte count after 19 exposures to 316
ppm from 7500 lymphocytes to 300 lymphocytes per
microliter. Two-day exposure to 3000 ppm resulted in a
reduction from 6700 in the sham-exposed to 3300/MiL in
the benzene-exposed 1 day after the end of exposure.
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FIGURE 5. Comparison of blood neutrophil and lymphocyte counts in
CBA/Ca BNL male mice that had inhaled the same total amount of
benzene over 19 or 2 days.
Thirty-two days after exposure there was still a marked
reduction in the lymphocyte level in the animals receiv-
ing 316 ppm over 19 days compared to the mice receiv-
ing 3000 ppm over 2 days. These differences still per-
sisted at 66 to 67 days and 214 days after exposure (Table
1).
The neutrophil counts 1 day after exposure showed a
significantly more severe neutropenia in the mice receiv-
ing 316 ppm for 19 exposures than in the mice receiving
3000 ppm in two exposures. Thirty-two days after ex-
posure and 66 to 67 days after exposure a slight neutrope-
nia was still present with no significant difference be-
tween the two exposure regimens. By 214 days after
exposure the mice that had been exposed to 3000 ppm
had recovered, but those that had been exposed to 316
ppm were still neutropenic.
Figure 6 shows the results of inhaled benzene on mar-
row cellularity and CFU-S content. One day after termi-
nation of exposure, the reduction in cellularity in the
animals receiving 316 ppm for 19 days was significantly
greaterthanthatofthe micethatreceived3000 ppm over
2 consecutive days. At 32, 66 to 67, and214 days after ex-
posure cellularity had returned to that of the sham-
exposed mice. The reduction in CFU-S content 1 day af-
ter exposure in the mice receiving 316 ppm for 19 days
was substantially and significantly greater than in the
animals receiving 3000 ppm for 2 consecutive days.
Thirty-two days after exposure the CFU-S contentofthe
marrow in the mice receiving 316 ppm was significantly
less than that ofthe sham-exposed animals, whereas the
mice that had received 3000 ppm for 2 consecutive days
the CFU-S had returned to that of the sham-exposed
animals. Inthe 300-ppm group CFU-S content ofmarrow
returned to shamlevels by 66 days after exposure. How-
ever, in the 316-ppm group the CFU-S remained signifi-
cantly below the sham levels at 214 days after exposure.
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FIGURE 6. Comparison of bone marrow cellularity and femoral CFU-S
in CBA/Ca BNL male mice that received the same total amount of
benzene over 2 days (3000 ppm) or 19 days (316 ppm).
Table 1. Comparison ofdifferential leukocyte counts in sham-exposed CBA/Ca BNL mice and mice that inhaled 316 ppm for nineteen 6-hr
exposures.a
Time after Neutrophil, Lymphocyte, Monocyte, Eosinophil,
treatment Group WBC, x 1034IIL x 103I*L x 103/AL x 103/4L x 1024/L LUC, x 102/ILb
ld Sham 10.4 + 0.9 2.2 ± < 0.1 7.5 ± 1.0 4.0 ± 0.6 2.6 ± 0.5 0.4 ± 0.1
Benzene 0.8 ± < 0.1 0.3 + < 0.1 7.1 ± 0.3 2.5 ± 0.5 0.1 ± 0.1 0.2 + < 0.1
32d Sham 10.3 ± 0.9 2.0 ± 0.2 7.6 ± 0.7 3.9 + 0.5 2.4 + 0.4 0.4 ± 0.1
Benzene 3.4 ± 0.4 1.4 ± 0.2 1.5 + 0.2 2.7 ± 0.3 1.9 ± 0.5 1.0 ± 0.5
67d Sham 7.9 ± 0.1 1.9 + 0.1 5.3 ± 0.2 3.3 ± 0.2 2.8 + 0.6 0.5 ± 0.2
Benzene 3.3 + 0.3 1.1 ± 0.1 1.9 ± 0.2 1.7 ± 0.3 1.1 ± 0.1 0.3 ± 0.2
214d Sham 10.0 ± 0.2 1.8 ± 0.1 7.1 ± 1.3 8.0 ± 1.8 2.2 + 0.6 0.8 ± 0.3
Benzene 5.5 ± 1.1 0.9 ± 0.1 3.9 ± < 0.1 5.9 ± < 0.1 0.7 ± 0.1 0.7 ± 0.5
aValues are means ± SE.
bLUC, large, unstained cell, mainly large lymphocytes.
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FIGURE 7. Femoral cellularity and CFU-S content as percent of the
sham-exposed mice after inhalation of3000 ppmbenzene foreight 6-hr
sessions or300ppm for eighty 6hr sessions (C57BL/6BNL females).
Table 1 shows the actual differential leukocyte counts
in number per microliter in CBA/Ca BNL mice that in-
haled 316 ppm benzene for nineteen 6-hr sessions. All of
the cell types are reduced in number as compared to the
sham-exposed mice at 1 day. All absolute counts except
the large unstained cells (LUG) are depressed at 32, 67,
and 214 da.ys after exposure. Figure 7 shows the serial
changes in the bone marrow cellularity and CFS-S in
C57B1/6BNL mice that inhaled 300 ppm for eighty 6-hr
sessions compared to mice that inhaled 3000 ppm for
eight sessions-the same total amount over one-tenth the
time.
The marrow cellularity and CFU-S ofmice thatinhaled
3000 ppm for eight sessions are depressed one day after
termination ofexposure butrebound toage-matched con-
trol by 30 days after exposure. The decrease in marrow
cellularity of mice that inhaled 300 ppm for eighty ses-
sions is nearly the same as in mice that inhaled 3000ppm
for eight sessions, but it takes 60 days to return to the
level of the age-matched, sham-exposed controls. The
CFU-S is decreased to 38% ofsham-exposed controls in
mice that inhaled 300 ppm compared to 62% in the mice
that inhaled 3000 ppm. The recovery in the CFU-S was
much slower and incomplete 178 days after exposure.
Mortality and Neoplasia
Figure 8 shows the mortality in sham- and benzene-
exposed male and female CBAiCa BNL mice inhaling300
ppm benzene 6hr/day, 5days/week for 16 weeks. Deaths
commenced in the sham-exposed males at about 600 days
of age with a median lifespan of 1030 days compared to
deaths commencing during exposure in the male mice
with a median lifespan of510 days. The sham-exposed fe-
males commenced dying at about 680 days of age with a
median life-span of 1100 days. This is compared to the fe-
male exposed mice that commenced dying shortly after
end ofexposure with a median lifespan of580 days. Un-
fortunately, the carcasses ofthe male mice that died dur-
AGE (days)
FIGURE 8. Mortality curves for male and female CBA/Ca BNL mice
that inhaled 300ppmbenzene 6hr/day, 5days/weekfor 16weeks com-
pared to the sham-exposed mice.
ingexposure were not saved. Itisassumedwithoutproof
that they were dying from the sequelae of marrow
hypoplasia.
Figure 9 shows the appearance of myelogenous ne-
oplasms, which is the sum ofneoplasms resemblingacute
myeloblastic and chronic granulocytic leukemia. None
were observed inthe sham-exposed males. Thebenzene-
exposed males began to develop myelogenous neoplasms
shortly after exposure, attaining a 19.3% lifetime inci-
dence at about 530 days ofage. Females developed my-
elogenous neoplasms later that first appeared at about
350 days of age with a lifetime incidence of 11.1%, com-
paredto alifetimeincidence inthe sham-exposedfemales
of 2%. See Table 2 for statistical significance of differ-
ences.
Figure 10 shows the appearance oflymphomatous ne-
oplasms, whichis the sum ofsolitarylymphomas, diffuse
nonthymic non-Hodgkins lymphoma, and Hodgkins lym-
phomata. This is alate-appearing spectrum ofdiseases in
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FIGURE9. Incidence curves formyelogenousneoplasms (acute myelob-
lactic and chronic granulocyticleukemia)formale andfemale CBA/Ca
BNL mice after inhalation of300 ppm benzene for eighty 6-hr ses-
sions.
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Table 2. Final incidence (%) ofvarious neoplastic conditions among CBA/Ca BNL mice that inhaled300ppm benzene or were sham-exposed.
Sham males, Benzene males, Sham females, Benzene females,
Condition n = 60 n = 57 n = 60 n = 54
Lymphomatous neoplasms 11.7 1.8 (0.037)a 8.3 7.4 (> 0.200)
Myelogenous neoplasms 0.0 19.3 (< 0.001) 1.7 11.1 (0.040)
Hepatomata 26.7 10.5 (0.028) 13.3 0.0 (0.006)
Neoplasms other than
hepatomata and
hematopoietic 21.7 52.6 (< 0.001) 35.0 79.6 (< 0.001)
aNumbers in parentheses are p values, X2 test.
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FIGURE 10. Incidence curves forlymphomatous neoplasms (Hodgkins,
non-Hodgkins lymphoma, and reticulum cell sarcoma) for CBA/Ca
BNL male and female mice that inhaled 300 ppm benzene 6 hr/day,
5 days/week for 16 weeks compared to the sham-exposed mice.
the sham-exposed animals with first appearance at about
880 days of age in the males attaining a lifetime incidence
of 11.7% in the males and 8.3% in the females. In both
sexes benzene exposure results in an earlier onset in the
appearance oflymphomatous neoplasms to a lifetime in-
cidence of7.4% in the females and 1.8% in the males. The
lifetime incidence is significantly lower in the benzene-
exposed males, and there is no significant difference in
the benzene-exposed females when compared with their
respective sham-exposed cohorts. It shouldbe noted that
lymphomatous neoplasms occurspontaneously late inthe
mouse's life. Due to the high mortality in the benzene-
exposed mice, few animals lived to an age atwhichthese
diseases normally appear. See Table 1 for statistical sig-
nificance.
Figure 11 shows the occurrence of nonhematopoietic
and nonhepatic neoplasms ofmale and female mice that
inhaled 300 ppm ofbenzene for6hr/day, 5 days/week, for
16 weeks. These neoplsams are primarily a combination
ofHarderian and Zymbalgland, squamous cell carcinoma,
mammary adenocarcinoma, and papillary adenocarci-
noma of the lung. In sham-exposed male mice these
tumors commenced at 780 days of age with a lifetime in-
cidence of21.7%. In the benzene-exposed males appear-
ance commenced shortly after cessation of exposure
reaching a lifetime incidence of52.6% (p > 0.001). In the
female sham-exposed (incidence 35.0%)these tumors com-
menced appearance at about 900 days of age. In the
benzene-exposed females these tumors commenced ap-
pearance at 360 days of age with a lifetime incidence of
79.6% (p > 0.001).
Amongmales exposed to benzene that died after com-
pletion of exposure and which were neoplasm-free on au-
topsy, one-half (3/6) were found to have hypoplastic or
aplastic bone marrow. This condition was first found at
339 days of age, 143 days after completion of exposure.
Among sham-exposed males, however, while the inci-
dence was similar(13/28), thefirst appearance was not un-
til 58Q days of age.
Among benzene-exposed females (1/4), the first inci-
dence of marrow failure came at 480 days of age while
amongsham-exposed-females, though the incidence was
similar (2/7), the age at onset was much later (949 days
of age). These findings show that in animals that died
without neoplasm bone marrow hypoplasia/aplasia oc-
curred much earlier in benzene-treated groups.
Figure 12 shows the comparison of mortality in male
CBA/Ca BNL mice that inhaled 100 ppm 6 hr/day, 5
days/week, for 16 weeks. The sham-exposed mice com-
menced to die at 630 days ofage compared to deaths dur-
ing exposure to benzene. Unfortunately, the carcasses
were not saved, so cause ofdeath during exposure is not
known. The median survival is 1020 days in sham-
exposed compared to 1000 days in benzene exposed. The
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FIGURE 11. Incidence curves for neoplasms other than hematopoietic
and hepatic (Zymbal, Harderian, mammary adenocarcinoma breast,
squamous cell carcinoma, papillary adenocarcinoma oflung, and be-
nign tumors) for male and female CBA/Ca BNL mice that inhaled 300
ppm benzene 6 hr/day, 5 days/week for 16 weeks compared to the
sham-exposed mice.
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FIGURE 12. Incidence curves for mortality ofmale CBA/Ca BNL mice
that inhaled 100ppmbenzene 6hr/day, 5days/weekfor 16weeks com-
pared to sham-exposed mice.
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FIGURE 13. Incidence curves forlymphomatous neoplasms in CBA/Ca
BNL male mice that inhaled 100 ppm benzene 6 hr/day, 5 days/week
for 16 weeks compared to the sham-exposed mice.
25% mortality in sham-exposed was attained at960 days,
compared to 840 days in the benzene exposed.
Figure 13 compares the incidence oflymphomatous ne-
oplasms in sham- and benzene-exposed male mice (100
ppm). The benzene-exposed mice had a lifetime incidence
of8.2% compared to 17.1% in the sham-exposed mice, in-
dicating that benzene exposure decreased the incidence
of lymphomata (p = 0.1).
Figure 14 compares the incidence curves for non-
hematopoietic nonhepatic neoplasms in male CBA/Ca
BNL mice that had inhaled 100 ppm benzene. The life-
time incidence in sham-exposed was 20% compared to
44.7% inmice that inhaled benzene (100ppm) (p > 0.001).
Incidence curves for hepatomata in male and female
mice show a lower incidence in male mice inhaling 300
ppm26.7% compared to 10.5% (p < 0.028). In females the
difference was more striking 13.3% (sham) to 0% in 300
ppm (p = 0.006). There was no significant difference in
male mice inhaling 100 ppm for 16 weeks.
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FIGURE 14. Incidence curves for neoplasms other than hematopoietic
and hepatic (Zymbal, Harderian, mammary adenocarcinoma breast,
squamous cell carcinoma, papillary adenocarcinoma oflung, and be-
nign tumors) for male and female CBA/Ca BNL mice that inhaled 100
ppm benzene 6 hr/day, 5 days/week for 16 weeks compared to the
sham-exposed mice.
Table 2 lists the final incidence of the different goups
of neoplasms and the probability of a significant differ-
ence fromthe incidence.in sham-exposedmale andfemale
CBA/Ca mice. In both sexes benzene (300 ppm) induced
a significant increase in myelogenousneoplasms and non-
hematopoietic nonhepatic neoplasms. In contrast to this
the final incidence of hepatomata is significantly
decreased by inhalation of benzene (300 ppm) in both
sexes and of lymphomata in males but not females.
Table 3 lists thefinal incidence ofneoplasms in CBA/Ca
male mice that inhaled 100 ppm benzene for 16 weeks.
There is alesserincidence oflymphomata in the benzene
exposed mice ofborderline significance. There is no sig-
nificant difference in myelogenous orhepatic neoplasms.
Neoplasms otherthanhemopoeitic andhepatic neoplasms
are significantly increased (p = 0.001).
Last, in studies still in progress using both female
C57B1/6 BNL and male CBA/Ca BNL mice, inhaling
3000 ppmfor8 days has not be leukemogenic or carcino-
genic. Although it would be premature to draw any final
conclusions, clearly, the early and high incidences ofmor-
tality and neoplasms seen in comparable 300 ppm-for-80
days experiments have not occurred. These animals are
now approaching 700 days of age.
Table3. Final incidence (%) ofvariousneoplastic conditions among
CBA/Ca BNL mice exposed to 100 ppm benzene- or sham-exposed.
Sham males, Benzene males,
Condition n = 70 n = 85
Lymphomatous neoplasms 17.1 8.2 (0.10)a
Myelogenous neoplasms 0.0 2.4 (0.19)
Hepatomata 38.6 41.2 (< 0.20)
Neoplasms other than
hepatomata and
hematopoietic 20.0 44.7 (0.001)
aNumbers in parentheses are p values, X2 test.
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Discussion
There have been many reports on the effect ofbenzene
on hematopoietic stem cells andearlyprogenitors(24-31).
All studies show that benzene inhalation of 100 ppm or
more reduces the number ofhematopoietic stem cells and
early progenitors. Baarson et al. (28) showed that ex-
posure to 10 ppm 6 hr/day for 5 days/week for 178 days
reduces the BFU-E to 55% ofcontrolsafter66 dayswith
a return to normal despite continued exposure. CFU-E
fell to 5% ofthe level in sham-exposed mice with only a
modest decrease in red blood cell levels in the blood. If
the CFU-E is an obligatory pathway to the circulating
red cell, one would have expected a severe anemia 15%
ofnormal. As this did not happen, onewonders iftheben-
zene metabolites interfere with synthesis or function of
the CFU-E receptors so that the in vitro stimulating
molecules are ineffective. Ifthe in vitro assays are cor-
rect, then the few remaining CFU-E must have a much
greater amplification orthe invitro CFU-E may not rep-
resent an obligatory step in vivo. Baarson et al. (unpub-
lished) found that consumption of5% ethanol in drinking
waterenhanced the effectof10 ppmbenzene in air. Seidel
et al. (31) exposed mice to 300 ppm 6hr/day, 5 days/week,
for 16 weeks and observed changes in the CFU-E and
CFU-E of lesser magnitude than Baarson et al. (28).
Whetherthese represent strain differences or differences
in sensitivity ofthe in vitro cultures is unclear. Seidel et
al. (31) also showed that after 4 weeks ofsham exposure
andbenzene (300ppm) exposure micehadalmost anequal
reticulocyte response to bleeding, suggesting that anemia
to a large extent may be due to hemolysis. We have ob-
served intense hemosiderosis in spleens indicating hemol-
ysis. Our studies in Hale-Stoner male mice exposed to 400
ppm benzene for 9.5 weeks did not develop as severe a
decrease in CFU-E as in the Baarson et al. (28) study.
Whether this is because ofstrain differences or to differ-
ences in assay system is not known.
Moeschlin and Speck (29) and Kissling and Speck (30)
concluded that administration ofbenzene results in inhi-
bition of DNA synthesis in the bone marrow. The over-
all reduction ofDNA synthesis in the bone marrow may
be the result ofcell killing. Cronkite et al. (24,25) focused
on the hematopoietic stem cells determining the fraction
in DNA synthesis by 3H-thymidine cytocide. There is a
marked increase in the fraction of CFU-S in DNA syn-
thesis compensating for the reduced number of CFU-S
in the bone marrow, not a decrease in fraction in DNA
synthesis as reported earlier.
The serial transfer ofsyngeneic bone marrow in irradi-
ated hosts was first reported by van Bekkum and
Weyzen(32). Mice arefatally irradiated and then rescued
by large bone marrow transplant of 106 to 107 syngeneic
bone marrow cells. At variable times after irradiation and
rescue bone marrow transplantation, the survivors are
used for donors in the second rescue. This isrepeated un-
til the bone marrow that has never been irradiated be-
comes exhausted. This has been termed decline in colony-
forming ability of marrow cells subjected to serial trans-
plantation into irradiated mice by Siminovitch, Till, and
McCulloch (33). This phenomenon of decline has been
studied by numerous investigators (33-41). Most inves-
tigators believe that the decline is due to exhaustion of
the finite mitotic capacity ofthe HSC. Our studies (un-
published)indicate that prolonged restsof100 to200 days
after three rescue transplants allow the HSC to regain
theirmitoticcapacity. Brecheretal. (unpublished)believe
decline in mitotic capacity is due to malfunction of the
marrow stroma in failing to provide adequate
hematopoietic molecular regulators. Studies reported
herein clearly show that bone marrow from mice that
havepreviously beenexposed to benzene for 752 days is
lesseffective inmaintaininglong-term survivalofrescued
mice and declines more rapidly than the bone marrow
from the sham-exposed donors. Alternative explanations
arepossible. The declinemaybe due to a)along-standing
genetic injury to the pluripotent hematopoietic stem cells
byfailureto repairDNAadductsorotherinjuryto DNA;
b) exhaustion ofthe Go stem cells byincreasingthe frac-
tion that were in DNA synthesis duringthe 16 weeks of
exposure to benzene thus exhaustingthe ultimate mitotic
capacity ofthe Go hematopoietic stem cells by repetitive
mitoses early in life; and c) a radiation effect on the
stromal cellsoftherecipientas suggestedby Brecher(un-
published). This would suggest that the benzene-treated
stem cells are more susceptible to stromal defect.
The inhalationof316 ppmbenzenefor 19 daysfrom an
exposure standpoint is equivalent to inhaling 3000 ppm
for2 days (each equivalent to 6000 ppm days). However,
there arelarge differencesinthehematologic effects. The
longer exposure to a lower concentration of benzene
results in a muchgreaterhematotoxic effect. The greater
effectofthe lowerconcentration ofbenzene overalonger
interval might be due to saturation ofthe enzymes that
metabolize benzene when inhaling 3000 ppm whereas in-
haling300ppmratherthan 3000ppmallows alargerfrac-
tion of the benzene to be metabolized. This question
mightbe answeredbymeasuringtotalphenolproduction
in both instances. A comparison of the effects of single
doses ofionizingradiationwith chronic exposure to ioniz-
ingradiation is ofcollateral interest. Single doses ofioniz-
ing radiation are much more effective in cell killing and
carcinogenesis thanthe same amountofionizingradiation
protracted over alongertime. Thisisgenerallyassumed
to be due to repair of injury to DNA.
The reverse maybe the case with exposure tobenzene
withirreparable injurybuildingup withtime. Inthe case
of 3000 ppm benzene exposure for 6 hr/day, there is a
daily 18-hrintervalforrepair. Inthe case ofnineteen6-hr
exposures to 300ppmbenzene 5 days/week, there is also
a daily 18-hr interval for repair and 60 hr from 4:00 P.M.
on Friday to 8:00 A.M. Monday. In the former case there
is either lesser injury or more repair. It had been in-
tended to repeat studies at more concentrations to see if
prolongation ofexposure tothe same totalamountofben-
zenewould continue to have agreaterhematotoxic effect
andwhetheritwouldhave agreaterleukemogenic effect.
Theinhalationof300 ppm 6hr/day, 5 days/weekfor 16
weeks drastically reduces the median survival time and
maximum survivaltime. Alargefractionofthereduction
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in survival time is due to an earlier onset and higher in-
cidence ofmalignant neoplasms. The deathsthatoccurred
during exposure are presumed due to the sequelae of
bone marrow-hypoplasia, butthis is notknown since the
carcasses were not saved. This assumption is supported
by the observation of earlier marrow hypoplasia in
benzene-exposed mice. In males and females there is a
highly significant increased incidence ofmyelogenous ne-
oplasms occurring earlier inlife. There is also avery sig-
nificant, earlier andhigherincidence ofneoplasms other
than hematopoietic and hepatic. Theseneoplasms consti-
tute abroad spectrum oftumors including squamous cell
carcinoma, mammary adenocarcinoma, Zymbal and
Harderian gland tumors, and papillary adenocarcinoma
ofthe lung. Lymphomatous neoplasms appear earlier in
the mice exposed to benzene than in the sham-exposed
mice. Lifetime incidence is slightly less in the case ofthe
benzene-exposed females, but in the case ofthe males is
significantly less.
Hepatic neoplasms appeared sooner in the benzene-
exposed mice with strikingly reduced lifetime incidence.
The reduction in incidence ofspecific types ofneoplasms
in the mouse by benzene exposure is apparently a new
observation. The phenomenon, however, was first ob-
served by Hellman et al. (42) in the Fischer rat exposed
to ionizingradiation. This rat has ahigh spontaneous in-
cidence of acute myelogenous leukemia. Exposure to
ionizingradiation drasticallyreducestheincidence ofmy-
elogenous leukemia, but increases the incidence ofmam-
maryadenocarcinoma. Theytermedthis aparadoxical re-
sponse to ionizing radiation. Presumably, this is due to
radiosensitivity of the target cells for leukemia that
would produce the neoplasms spontaneously. It is as-
sumed that a comparable mechanism is operating in the
reduction by benzene of the incidence of neoplasms in
CBA/Ca BNL mice that have a high spontaneous inci-
dence. Stoner, Drew, and Bernstein (43) conducted life-
time benzene exposures to hairless mice. The incidence
ofleukemia was not increased. In fact, aninterpretation
oftheir data suggests that exposure tobenzene by inha-
lation mayhave suppressedthe development ofleukemia.
The first experimental demonstration ofcarcinogene-
sis by benzene is that ofMaltoni and Scarnato (44), who
administered large amounts ofbenzene by stomach tube
forlongperiods oftime inthe Sprague-Dawley rats. They
developed a wide spectrum ofmalignant and nonmalig-
nant neoplasms.
Snyder et al. (45) exposed C57BL/6 and AKR mice to
300ppm, 6hr/day, 5 days/weekfor alifetime. There was
a significant increase in the incidence of leukemia and
lymphoma. In studies onrats exposedto 100 ppmforlife-
time, a single case of chronic myelogenous leukemia, a
rarity in the rat, was observed by Goldstein et al. (46).
Another study by Snyder et al. (47) showed severe
hematoxicity after inhaling 100 ppm benzene in air, but
no significant increase inhematopoietic neoplasms. There
was a significant increase in the nonhematopoietic neo-
plasms. A recent monographoubenzene carcinogenicity
byAskoy (48)repeatedly points out that there is no ani-
mal model for benzene induction of acute myelogenous
leukemia. Our studies correct this deficiency.
Harigaya et al. (49) adopted another approach for the
detection ofhematotoxicity ofbenzene andpossible car-
cinogenic effect. In these studies C57BL/6Jmice were ex-
posed to 400 ppm benzene 6 hr/day, for either 9 days or
for 11 consecutive days. Long-term bone marrowcultures
of bone marrow from benzene-exposed mice showed a
progressive reduction in the number of spleen-colony
forming cells compared to bone marrow from control
mice. Different combinations of adherent cells and
reinoculated cells showed that cultures containing bone
marrow cells frombenzene-exposed mice had a lower ca-
pacity to maintain stem cellproliferation in normal com-
binations irrespective ofwhether benzene-exposed mar-
row was in the adherent cell layers orreinoculated cells.
Clearly, benzene inhalation of this magnitude produces
stem cell injuryleading to diminished self-replication and
derangement of the adherent marrow population. The
long-term marrow cultures from the benzene-treated
mice did not develop detectable transformation in vitro
throughout the culture period. Neonatal mice inoculated
with cultured cellsfrom thebenzene-exposedmice didnot
develop leukemia during an 8-month period after inocu-
lation when the study was terminated. Subsequent
studies suggest that alonger exposure ofdonormice and
a longer observation of the recipient mice may be indi-
cated.
It has been known for years by the present investiga-
tors that four strains ofmice developed an increased in-
cidence ofacute myelogenous leukemia after exposure to
ionizing radiation (50-54). The RFM strain is less desira-
ble because ofexpense and it has a high spontaneous in-
cidence of acute myeloblastic and other leukemias. The
C3H/He male mouse has alow spontaneous incidence of
acute myeloblastic leukemia, but the female has such a
high and early incidence ofmammary neoplasms that it
would be undesirable. The SJL/J mouse is rather expen-
sive and less easily obtained in numbers. The CBA/H
male mouse inEngland has avery lowincidence ofacute
myeloblastic leukemia (< 1%), butresponds to exposure
to ionizing radiation with a high incidence. The CBA/Ca
fromJackson Laboratories comes fromthe same stockas
the CBA/H in England and was therefore chosen as the
best andmosteconomical ofthe four strains known to de-
velop acute myeloblastic leukemia. The choice appears to
haveprovided agood animal model forthe study ofben-
zeneleukemogenesis and shouldbe suitable forestablish-
ment ofthe needed benzene dose-effect curves for acute
myelogenous and other leukemias. Our data suggestthat
there may be an effective time-dose relation (or concen-
tration) ofbenzene that may not increase the incidence
of myelogenous neoplasms, but will induce other ne-
oplasms. Our data suggest thatexposure to 100ppmben-
zene 6hr/day, 5 days/weekfor 16 weeks may be close to
such a time-dose threshold for myelogenous leukemias.
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